Chart calendar Pfizer Inc.

0e57d8984b27358a952714186.uFPJ89djk6om7_nQU493Ukxg-6CoA5PyN_eqyRV2UbM.iBm-gIgB-MdTl8H9a-o6IyUwlf_Lc9_GW7_yv2JPaNrINqOiuzrH-FK6ig~e40a430f02eadfedbd92552e67ebb4fa

Upcoming events on Pfizer Inc.

2026-01-22

Ex-dividend day

2026-02-03

Q4 2025 Earnings Release

2026-02-03

Q4 2025 Earnings Call

2026-05-04

Q1 2026 Earnings Release (Projected)

2026-08-03

Q2 2026 Earnings Release (Projected)

2026-11-02

Q3 2026 Earnings Release (Projected)

2027-02-01

Q4 2026 Earnings Release (Projected)

Past events on Pfizer Inc.

Today

J.P. Morgan Healthcare Conference

2025-12-16

Q4 2026 Guidance Call

2025-11-19

Jefferies Global Healthcare Conference

2025-11-10

Business Update Call

2025-11-06

Ex-dividend day

2025-11-04

Q3 2025 Earnings Call

2025-11-04

Q3 2025 Earnings Release

2025-10-20

European Society of Medical Oncology Congress - Oral Presentation No:489MO

2025-10-20

European Society of Medical Oncology Congress - Oral Presentation No:485MO

2025-10-20

European Society of Medical Oncology Congress - Oral Presentation No:729O

2025-10-19

European Society of Medical Oncology Congress - Oral Presentation No:1329MO

2025-10-19

European Society of Medical Oncology Congress - Oral Presentation No:LBA87

2025-10-19

European Society of Medical Oncology Congress - Oral Presentation No:LBA86

2025-10-19

European Society of Medical Oncology Congress - Oral Presentation No:1849MO

2025-10-18

European Society of Medical Oncology Congress

2025-10-17

European Society of Medical Oncology Congress - Oral Presentation No:LBA102

2025-09-22

Acquisition of Metsera, Inc by Pfizer Inc Call

2025-08-05

Q2 2025 Earnings Call

2025-08-05

Q2 2025 Earnings Release

2025-07-25

PD-1 x VEGF Bispecific Antibody Call

Past dividends on Pfizer Inc.

2025-11-06

Quarterly 0.43 USD

2025-07-24

Quarterly 0.43 USD

2025-05-08

Quarterly 0.43 USD

2025-01-23

Quarterly 0.43 USD

2024-11-07

Quarterly 0.42 USD

2024-07-25

Quarterly 0.42 USD

2024-05-08

Quarterly 0.42 USD

2024-01-24

Quarterly 0.42 USD

2023-11-08

Quarterly 0.41 USD

2023-07-26

Quarterly 0.41 USD

2023-05-10

Quarterly 0.41 USD

2023-01-25

Quarterly 0.41 USD

2022-11-02

Quarterly 0.4 USD

2022-07-27

Quarterly 0.4 USD

2022-05-11

Quarterly 0.4 USD

2022-01-26

Quarterly 0.4 USD

2021-11-03

Quarterly 0.39 USD

2021-07-28

Quarterly 0.39 USD

2021-05-05

Quarterly 0.39 USD

2021-01-27

Quarterly 0.39 USD

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
100 330
100 373
-0.04%
58 496
59 105
-1.03%
63 627
63 071
0.88%

61 967


60 994


59 110

EBITDA
Million USD
Released
Forecast
Spread
42 336
44 597
-5.07%
15 590
11 249
38.59%
28 801
25 014
15.14%

24 707


24 975


23 602

EBIT
Million USD
Released
Forecast
Spread
37 272
40 403
-7.75%
9 300
8 509
9.3%
21 788
20 589
5.82%

21 253


21 336


20 225

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
34 729
39 058
-11.08%
1 058
2 301
-54.02%
8 023
11 544
-30.5%

12 664


14 872


14 300

Net income
Million USD
Released
Forecast
Spread
31 372
33 053
-5.09%
2 119
3 040
-30.29%
8 031
9 732
-17.47%

11 638


12 883


12 472

EPS
USD
Released
Forecast
Spread
5,47
5,85
-6.45%
0,37
0,72
-48.44%
1,41
1,70
-17.17%

2,03


2,22


2,16

Announcement Date31/01/2330/01/2404/02/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3
Net sales
Million USD
Released
Forecast
Spread
14 879
13 923
6.87%
13 283
13 019
2.03%
17 702
14 865
19.08%
17 763
17 264
2.89%
13 715
14 051
-2.39%
14 653
13 531
8.29%
16 654
16 502
0.92%

16 912


13 982


14 501


16 023


16 407


13 810


14 505


16 345

EBITDA
Million USD
Released
Forecast
Spread
7 648
4 403
73.7%
5 906
3 663
61.26%
7 478
4 647
60.92%
6 391
4 136
54.54%
7 548
6 180
22.14%
6 940
5 487
26.49%
7 303
6 229
17.23%

5 926


7 031


6 927


7 066













EBIT
Million USD
Released
Forecast
Spread
5 912
3 667
61.24%
4 175
3 346
24.78%
7 035
3 978
76.86%
4 672
3 357
39.18%
5 930
4 982
19.02%
5 315
4 410
20.51%
5 641
4 704
19.93%

4 205


5 523


5 381


6 115


5 236










Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
3 421
2 992
14.34%
-103
2 049
-105.03%
4 715
2 616
80.24%
-10,0
2 104
-100.48%
2 785
3 880
-28.22%
3 044
2 468
23.34%
3 334
3 240
2.9%

3 002






















Net income
Million USD
Released
Forecast
Spread
3 115
1 951
59.69%
41,0
1 733
-97.63%
4 465
1 725
158.79%
410
1 002
-59.1%
2 967
2 913
1.86%
2 910
2 063
41.07%
3 541
2 334
51.72%

2 154


3 121


3 216


4 030


2 746










EPS
USD
Released
Forecast
Spread
0,55
0,34
61.01%
0,01
0,30
-96.67%
0,78
0,30
160.81%
0,07
0,20
-65.43%
0,52
0,51
2.91%
0,51
0,36
41.65%
0,62
0,44
42.49%

0,39


0,50


0,54


0,64


0,48










Announcement Date01/05/2430/07/2429/10/2404/02/2529/04/2505/08/2504/11/25--------
2026-01-15

Q3 2026 Earnings Release (Projected)

2026-01-15

Q3 2026 Earnings Release

2026-01-20

Q3 2026 Earnings Release

2026-01-20

Q4 2025 Earnings Release (Projected)

2026-01-21

Q4 2025 Earnings Release

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-22

Q3 2026 Earnings Release

2026-01-22

Q3 2026 Earnings Release

2026-01-27

Q3 2026 Earnings Release

More events

Past sector events for Pfizer Inc.

2026-01-10

December 2025 Sales and Revenue Release

2026-01-09

December 2025 Sales and Revenue Release

2026-01-08

December 2025 Sales and Revenue Release

2026-01-08

Q2 2026 Earnings Release

2026-01-08

December 2025 Sales and Revenue Release

2026-01-07

December 2025 Sales and Revenue Release

2026-01-05

Q3 2025 Earnings Release

2026-01-05

December 2025 Sales and Revenue Release

2025-12-22

Q3 2025 Earnings Release

2025-12-19

Q2 2026 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise